Parker Retzlaff is set to embark on a brand-new journey in the NASCAR O'Reilly Auto Parts Series for the 2026 campaign, signing a deal with Viking Motorsports t ...
motorsport.com on MSN
Parker Retzlaff to join Viking Motorsports in 2026
Parker Retzlaff will pilot the No. 99 Viking Motorsports Chevrolet in the 2026 NASCAR O'Reilly Auto Parts Series. Danny Efland will work with Retzlaff as the crew chief, coming over from Am Racing.
Even by his own prolific standards, Manchester City’s Erling Haaland is on an unprecedented tear this season, topping the ...
TravelNoire on MSN
Viking Cruises Just Reached 100 Ships — Here’s What That Means If You Love River Cruises
The post Viking Cruises Just Reached 100 Ships — Here’s What That Means If You Love River Cruises appeared first on Travel ...
A crew member went overboard from a Viking cruise ship in the Mediterranean. The incident occurred around 11:30 a.m. on Oct. 27, according to the cruise line. "The ship’s emergency response was ...
A powerful collection of timeless cinematic adventures exploring strength, survival, and legend through bold storytelling and ...
Viking Cruises marks a historic milestone in Basel, launching its 100th ship. Learn about the new fleet and its 'adults-only, ...
A crew member on board the 'Viking Star' cruise ship went overboard on Monday. The ship is currently sailing from Greece to ...
Management reassured investors that there could be substantial value in its lead drug candidate, VK2735.
Stocktwits on MSN
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
VKTX shares have surged about 45% in October, set for their strongest monthly gain of 2025. ・Traders on Stocktwits linked ...
The Viking Sea, classified as a small ship, carries under 1,000 passengers and features wrap-around verandas. At 745 feet, it can dock where larger vessels cannot, and Viking operates several ships of ...
24/7 Wall St. on MSN
Viking Therapeutics Could Be Pharma’s Next Big Buyout Target
The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results